[A long-term response to eribulin].

[A long-term response to eribulin]. Bull Cancer. 2018 Jun 14;: Authors: Patient M, Tsogou PTN, Roméo E, Bladé JS, de Jauréguiberry JP, Boudin L PMID: 29910045 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29910045?dopt=Abstract

Source: Bulletin du Cancer - June 14, 2018 Category: Cancer & Oncology Authors: Patient M, Tsogou PTN, Roméo E, Bladé JS, de Jauréguiberry JP, Boudin L Tags: Bull Cancer Source Type: research

More News: Cancer | Cancer & Oncology